Det vi støtter (kun på engelsk)

Funded projects
1,200+
Men's Health Partners
20
Countries
21
"We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact." - Owen Sharp, CEO
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“We’re alarmed by the increasing number of men who take their own lives around the world. We are working to ensure all men and boys look after their mental health and are comfortable to reach out to others for support when they’re struggling.” 
Craig Martin, Global Director - Mental Health & Suicide Prevention programs
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

Priority driven Collaborative Cancer Research Scheme 2007-2012

Movember Funding to Date

AUD 3,709,211

What we seek to achieve

To reduce the impact of cancer in the community and improve outcomes for people affected by cancer.To work collaboratively with organisations that support cancer research to generate evidence, increase knowledge, and improve the translation of research into policy and practice.

Country
Australia
Co-funded
Cancer Australia
Implemented by
Prostate Cancer Foundation of Australia
Project start date
July 2007
Project Status
Project Completed

About the project

The PdCCRS aims to fund research in tumour areas that place a high burden of disease on the Australian community; fund applied cancer research projects that directly relate to the identified priorities of Cancer Australia and PCFA and fund research that can directly improve cancer outcomes by influencing clinical practice, policy and/or care.

Research funded through this scheme is Outcome-/Impact-focused. Applicants must be able to demonstrate how their project has the potential to improve short, medium and long term outcomes in cancer care and/or cancer control. Applicants must demonstrate how their research will benefit populations with poorer outcomes within the community, such as Aboriginal and Torres Strait Islander peoples and those living in particular socioeconomic status areas and geographic locations.

Every project presents a clear pathway to translation; Applicants are required to describe the approaches and methodologies that will be employed to translate findings of the proposed research into clinical practice, policy, and/ or further research in order to improve cancer care and/ or cancer control. Applicants must also discuss how the proposed collaboration is necessary for the translation of results. All PdCCRS funded projects are collaborative. These project grants demonstrate necessary collaborations that may be cross-disciplinary, national, multi-state or international, and the applicants describe the specific role of the key collaborators in the project. Importantly, PdCCRS grants engage consumers. Consumer involvement in the project must be substantive, meaningful and bi-directional.

PCFA signs an annual co-funding agreement with Cancer Australia for a set amount of contribution which is matched dollar per dollar by Cancer Australia or/and other partners that participate in the scheme and fund prostate cancer research.

>
Page 1 of 19